In Situ Nitric Oxide Generating Nano‐Bioactive Glass‐Based Coatings and Its Therapeutic Ion Release toward Attenuating Implant‐Associated Fibrosis and Infection
Small · 2025-04 · 21 (13)
DOI: 10.1002/smll.202411984 ↗Kurz gefasst
Fachartikel in der Zeitschrift Small, online erschienen am 24.02.2025. Verfasst von Joseph Christakiran Moses und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Chemical, Materials and Biomedical Engineering, College of Engineering, University of Georgia, Athens, GA, 30602, USA. Hauptthemen laut MEDLINE: Nitric Oxide, Glass, Coated Materials, Biocompatible, Prostheses and Implants. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 74 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NHLBI NIH HHS, NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
Nitric oxide (NO) is a potent gasotransmitter that exhibits a pleiotropic effect in regulating homeostasis and pathophysiology. Though it is a versatile biomaterial, silicone‐based devices are still challenged by implant‐associated infections and fibrous capsule formation complications. Here, a NO‐generating (NOgen) interface is developed from copper or strontium‐doped mesoporous bioactive glass‐based coating on silicone substrates to facilitate metal‐ion catalysis of endogenous S‐nitrosothiols. The copper or strontium‐based interfaces can generate physiologically relevant NO levels, which have bactericidal and antithrombotic effects to combat implant‐associated early onsite infection and thrombosis. The NO generated in tandem with the low therapeutic release of strontium ions from the NOgen interface regulates cellular fate pertaining to fibroblasts, macrophages, and endothelial cells. Strontium suppresses the collagen expression and migration of activated fibroblasts while favoring M 2 phenotype bias in macrophages. Differential NO flux observed over time from NOgen interfaces helps switch macrophages from proinflammatory M 1 phenotype to M 2 anti‐inflammatory phenotype. Moreover, the synergistic effect of leachate and NO generated by the silicone substrate demonstrates a proangiogenic effect by aiding endothelial network maturation in vitro. Thus, the multifunctional features of the developed strontium‐doped bioactive glass‐based coating hold promise in regulating local immune‐micromilieu and attenuating implant‐associated fibrosis of silicone‐based implantable devices.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Chemical, Materials and Biomedical Engineering, College of Engineering, University of Georgia, Athens, GA, 30602, USA.
- Pharmaceutical and Biomedical Sciences Department, College of Pharmacy, University of Georgia, Athens, GA, 30602, USA.
ORCID-Profile: Joseph Christakiran Moses, Hitesh Handa, Elizabeth J Brisbois
Förderung
- NHLBI NIH HHS
- NIH HHS
- National Institutes of Health
Zitieren
APA
Moses, J. C., Sapkota, A., Wu, Y., Martinez, I., Handa, H., & Brisbois, E. J. (2025). In Situ Nitric Oxide Generating Nano‐Bioactive Glass‐Based Coatings and Its Therapeutic Ion Release toward Attenuating Implant‐Associated Fibrosis and Infection. Small, 21(13). https://doi.org/10.1002/smll.202411984
Vancouver
Moses JC, Sapkota A, Wu Y, Martinez I, Handa H, Brisbois EJ. In Situ Nitric Oxide Generating Nano‐Bioactive Glass‐Based Coatings and Its Therapeutic Ion Release toward Attenuating Implant‐Associated Fibrosis and Infection. Small. 2025;21(13). doi:10.1002/smll.202411984
BibTeX
@article{Moses2025,
author = {Moses, Joseph Christakiran and Sapkota, Aasma and Wu, Yi and Martinez, Isabel and Handa, Hitesh and Brisbois, Elizabeth J},
title = {In Situ Nitric Oxide Generating Nano‐Bioactive Glass‐Based Coatings and Its Therapeutic Ion Release toward Attenuating Implant‐Associated Fibrosis and Infection},
journal = {Small},
year = {2025},
volume = {21},
number = {13},
doi = {10.1002/smll.202411984}
}
EUVIMED